BOSTON SCIENTIFIC CORP — Director's Dealing 2015

May 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-05-04

Reporting Person: Ballinger Kevin J. (SVP & Pres, Interven Cardio)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-04	Common Stock	M	28122.0000	$6.2800	Acquired	91135.0000	Direct
2015-05-04	Common Stock	M	21878.0000	$6.3100	Acquired	113013.0000	Direct
2015-05-04	Common Stock	S	67964.0000	$17.9122	Disposed	45049.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-04	Stock Option (Right to Buy)	$6.2800	M	28122.0000	Disposed	2022-02-27	Common Stock (28122.0000)	Direct
2015-05-04	Stock Option (Right to Buy)	$6.3100	M	21878.0000	Disposed	2020-10-25	Common Stock (21878.0000)	Direct

Footnotes

F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.90 to $17.925, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on October 25, 2011, the first anniversary of the date of grant.